Questions Remain On Gilead’s Remdesivir

 
• By Joseph Haas
COVID-19 SARS,Coronaviridae , SARS-CoV, SARSCoV, virus 2020 , MERS-CoV ,chinese virus 2019-nCoV
Gilead now has data from three studies indicating remdesivir can benefit COVID-19 patients

More from COVID-19

More from Scrip